Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
THE SO WHAT
Emerging links between GLP-1 drugs and vision loss risk will push payers and providers to tighten monitoring and real-world evidence collection. Healthtech teams should expect demand for longitudinal safety analytics and patient-reporting tools around blockbuster therapies, not just prescribing workflows.
READ THE SOURCE
MORE FROM THE WIRE
Want to be an astronaut? NASA is accepting applications for the first time in 2 years.
NASA reopening astronaut applications is a reminder that human-in-the-loop space operations are not going away as automation rises. Space-adjacent companies should plan for mixed autonomy stacks where crewed missions and robotic systems co-evolve, not one replacing the other.
Deep & Emerging Tech8849 Tank 5 rugged phone review
A rugged phone with a strong SoC, solid cameras, a DLP projector, and thermal imaging is a reminder that niche devices can bundle multiple ‘good enough’ sensors into a field tool. For industrial and defense operators, specialized hardware may beat general-purpose phones plus accessories on reliability and deployment simplicity.
Deep & Emerging TechHundreds of copies of Chinese-made ARTEX hacking tools leaked online for anyone to use in further attacks
Commodity-grade nation-state tooling leaking at scale collapses the gap between top-tier and mid-tier attackers. Assume more capable intrusion attempts against your org and vendors—tighten detection around known toolchains, not just bespoke malware.
Deep & Emerging TechHonda will spend $3B on a new Ohio car plant built around hybrids
Honda’s $3B Ohio plant for 240,000 mostly hybrids a year — opening 2029 — is a bet that tariffs and consumer hesitation will keep pure EV penetration slower than the hype. Auto and mobility suppliers should not assume a straight-line EV future; hybrid-heavy lineups may stay a large, stable demand pool for at least the next product cycle.